|
Imported drugs plan fails
The Senate defeats an effort that would have allowed Americans to purchase
prescription drugs from abroad.
[Link is Broken]
Associated Press and Los Angeles Times
WASHINGTON - In a triumph for the pharmaceutical industry, the Senate on
Monday killed a drive to allow consumers to buy prescription drugs from abroad
at a significant savings over domestic prices.
On a 49-40 vote, the Senate required the Food and Drug Administration to
certify the safety and effectiveness of imported drugs before they can be
imported, a requirement that officials have said they cannot meet.
“Well, once again the big drug companies have proved that they are the most
powerful and best financed lobby in Washington,” said Sen. David Vitter,
R-La.
The vote neutralized a second amendment, later passed on a voice vote, that
would legalize the importation of prescription drugs manufactured in Canada,
Australia, Europe, Japan and New Zealand.
The drug import measure - which was tacked onto legislation for the
overhaul of the FDA - could have saved consumers billions of dollars, its
sponsors said.
But the pharmaceutical industry has argued that pharmacies risk being
flooded with counterfeit drugs. And the White House, which also opposes
importation, had threatened a veto of the drug safety bill if it eased
restrictions.
That put the Senate’s Democratic majority in a bind: Many favor direct drug
importation, but the amendment threatened to stymie a reform of the FDA that is
considered must-pass legislation.
So some Democrats straddled the issue by voting for both measures.
Washington Sens. Maria Cantwell and Patty Murray were among the 15
Democrats to vote in favor of the drug certification measure.
Sen. Byron Dorgan, D-N.D., accused the drug industry of wanting to dictate
prices to American consumers. “Yes, we have price controls in America,” he said.
“Not government price controls, but price controls by the pharmaceutical
industry.”
Sen. Thad Cochran, R-Miss., said the problem of counterfeit drugs was his
main concern. “Americans deserve continued access to safe and effective drugs,”
he said. “Serious problems exist with products from other countries.”
Overseas, drugs can cost two-thirds less than they do in the United States,
where prices for brand-name drugs are among the highest in the world.
In many industrialized countries, prices are lower because they are either
controlled or partially controlled by government regulation.
Similar drug-import legislation is pending in the House.
What happened The Senate effectively killed a bid to allow consumers to
buy prescription medicines abroad by voting to require U.S. officials to certify
the safety and effectiveness of such drugs - something health officials say they
cannot do.
The vote neutralized a second measure, later passed on a voice vote, that
would permit drug imports from FDA-approved sources in Canada, Australia,
Europe, Japan and New Zealand.
Drug-import legislation is still pending in the House.
|